Literature DB >> 8360581

Characterization and applications of antibodies produced in plants.

A Hiatt1, J K Ma.   

Abstract

Of the variety of compounds expressed in transgenic plants, antibodies offer probably the widest range of applications. The antibodies appear to possess all of the functional characteristics of antibody derived from hybridoma cells, although further study will be required to determine the effect of the difference in heavy chain glycosylation. More work will also be directed toward the assembly, accumulation, stability and secretion of plant antibodies. The effect of the signal sequence on the expression and assembly of antibodies has been shown and further methods of optimizing transgenic protein accumulation in plants almost certainly exist. Plant antibody technology is still in its infancy. However, it offers enormous potential in "mix-and-match" antibody engineering, and the construction of multimeric immunoglobulin complexes may be feasible relatively easily, for the first time. Furthermore, as there is an enduring interest in using antibodies for therapeutic purposes, agricultural production and distribution offers a means of obtaining large quantities of antibodies at a relatively low cost.

Mesh:

Substances:

Year:  1993        PMID: 8360581     DOI: 10.3109/08830189309061691

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  3 in total

1.  Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves.

Authors:  C Vaquero; M Sack; J Chandler; J Drossard; F Schuster; M Monecke; S Schillberg; R Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice.

Authors:  D Chargelegue; N D Vine; C J van Dolleweerd; P M Drake; J K Ma
Journal:  Transgenic Res       Date:  2000-06       Impact factor: 2.788

Review 3.  Molecular farming of pharmaceutical proteins.

Authors:  R Fischer; N Emans
Journal:  Transgenic Res       Date:  2000       Impact factor: 3.145

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.